Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis (Q45367090)
Jump to navigation
Jump to search
scientific article published on 26 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis |
scientific article published on 26 April 2011 |
Statements
1 reference
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis (English)
1 reference
Yu Xuan Koo
1 reference
Matthew Tay
1 reference
Yii Ean Teh
1 reference
David Teng
1 reference
Daniel S W Tan
1 reference
Iain B H Tan
1 reference
David W M Tai
1 reference
Richard Quek
1 reference
Miriam Tao
1 reference
Soon Thye Lim
1 reference
26 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference